QFA
STLN

Quattro Financial Advisors’s Starling Oncology STLN Stock Holding History

Quattro Financial Advisors’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-162,724
Closed -$186K – 91
2025
Q1 		$186K Hold
162,724
– – 0.06% 79
2024
Q4 		$113K Hold
162,724
– – 0.03% 84
2024
Q3 		$52.6K Buy
162,724
+106,764
+191% +$44.2K 0.01% 77
2024
Q2 		$25.7K Hold
55,960
– – 0.01% 75
2024
Q1 		$88.4K Buy
+55,960
New +$106K 0.03% 78

Other funds holding STLN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TAS
TIFF Advisory Services Radnor, Pennsylvania $408M AUM 20.34% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $2.04B AUM 35.27% 1-Year Est. Return

Quattro Financial Advisors's STLN Position: Q2 2025 in Review

Quattro Financial Advisors sold out of Starling Oncology (STLN) in Q2 2025, closing a stake of 162,724 shares — an estimated $186K sold.

Quattro Financial Advisors first reported a position in STLN in Q1 2024 and held it in 5 quarters. The position peaked at $186K in Q1 2025. 79 funds tracked by Wall St. Rank hold STLN as of Q2 2025.

  • Quattro Financial Advisors reported no remaining Starling Oncology position as of Q2 2025 after selling out during the quarter.
  • Quattro Financial Advisors sold 162,724 Starling Oncology shares in Q2 2025, an estimated $186K.
  • Quattro Financial Advisors first reported a position in Starling Oncology in Q1 2024 and held it in 5 quarters.
  • Quattro Financial Advisors's Starling Oncology position peaked at $186K in Q1 2025.
  • 79 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2025.

Based on Quattro Financial Advisors's 13F filing for Q2 2025, filed 21 Jul 2025.